FDA Clears Investigational New Drug Application for Inhaled COVID Biologic
Biotech company Ocugen, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared their Investigational New Drug (IND) application for a novel inhaled vaccine against SARS-CoV-2. The biologic uses novel chimpanzee adenovirus-vectored (ChAd36) technology. The approval will allow the company to initiate Phase I clinical trials for the inhaled vaccine, OCU500. The […]
First Severe Case of Human Bird Flu Confirmed in U.S.
Officials at the U.S. Centers for Disease Control and Prevention (CDC) have confirmed diagnosis of the first severe human case of “bird flu” or H5N1 avian influenza. They determined that the hospitalized patient, a resident of Louisiana, was exposed to “sick and dead birds in backyard flocks,” although the source of the infection in the […]
Monkeypox Fear Fest: Is Smallpox Vaccine on Its Way Back?
This article is an excerpt from a longer fully referenced report by NVIC co-founder and president Barbara Loe Fisher on Mutated Monkeypox Outbreaks and the Anticipated Return of Smallpox Vaccine, which can be read on NVIC.org. A day before the July 4, 2024 holiday, Business Insider published an article warning that “Experts are racing to […]
NIH Scientists Tried to Conceal $710 Million Pandemic Royalty Payout
Data from the U.S. National Institutes of Health (NIH) revealed that the nation’s medical research agency and its scientists collected hundreds of millions of dollars in royalties for COVID-19 pandemic-related drugs and vaccines between 2021 and 2023. This information was initially kept secret by the NIH. It was made public by OpenTheBooks.com, an organization that […]
Rand Paul Exposes the ‘Great COVID Cover-up’
In an explosive new op-ed, Sen. Rand Paul (R-KY) claimed that at least 15 separate federal agencies knew that attempts to create a COVID-19-like coronavirus were being undertaken at the Wuhan Institute of Virology as early as January 2018. Yet, heads of these agencies did not reveal this information to the public; for years, they actively refused to release information […]
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will […]